SBIR/STTR Research Award

Novel Device for Wound Irrigation and Debridement

Award identifier 214ed55f6b9f3d0209cfdba3f2d79af073e4a61910fc96aebc650545e5d54d4aAwarding agency Department of Defense · Army

Award amount

$729,665

Program and phase

SBIR · Phase II

Award year

2003

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Defense
Branch
Army
Recipient company
LYNNTECH INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
PMVAL8J63516
Solicitation number
Not reported
Topic code
Not reported

Research abstract

A significant number of bone and tissue combat injuries require surgical debridement, accompanied by irrigation with sterile water with simultaneous suction. While this approach to removal of devitalized tissue has been quite successful, a debrided woundoften becomes infected due to insufficient irrigation (volume) or direct contact with pathogens via the irrigation water or surgical materials. This problem is further complicated in battlefield scenarios where supply and casualty care logistics andavailability of sterile water are insufficient. To overcome these obstacles, Lynntech has developed a rugged, lightweight debridement irrigation device, which incorporates two electrochemical technologies in tandem. The device allows for in-linesterilization of any external source of potable water while providing a small amount of short-lived, safe, residual disinfectant to prevent infection. In Phase I, Lynntech successfully designed and fabricated the irrigation water system, including boththe deionization unit and the ozone generator and demonstrated its sterilization efficiency on a variety of potential source waters. Lynntech has also begun dialogue with a leading manufacturer of pulsatile irrigation devices, facilitatingcommercialization of the unit. The Phase II will focus on construction, testing, and delivery of the unit to be further tested in vivo for proof of performance and safety. Manufacture of sterile water at the point of use is attractive for uses within themedical/surgical areas and in general in water treatment. A direct avenue to commercialization is evident for military field hospitals, civilian emergency response (natural disasters), industrial first aid, rural and developing country medical treatment,and mobile veterinary care. A similar iteration of the device could also be used to treat drinking water in remote locations where pathogens are endemic or in areas that have had water quality compromised by microorganisms.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

1,079 SBIR/STTR records share this UEI (1988–2025). Reported award amounts total $327,411,388. Reported amounts are not federal obligations.

Phases: Phase I, Phase II, Phase II – Direct to Phase II

Agencies: Department of Defense, Department of Health and Human Services, National Aeronautics and Space Administration, Department of Energy, National Science Foundation, Environmental Protection Agency

Agency intelligence

Department of Defense

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.